Vanguard Group’s Axcella Health Inc. Common Stock AXLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-32,034
| Closed | -$334K | – | 4592 |
|
|
2023
Q3 | $334K | Sell |
32,034
-903
| -3% | -$7.1K | ﹤0.01% | 4162 |
|
|
2023
Q2 | $180K | Hold |
32,937
| – | – | ﹤0.01% | 4326 |
|
|
2023
Q1 | $395K | Buy |
32,937
+2,155
| +7% | +$28.7K | ﹤0.01% | 4185 |
|
|
2022
Q4 | $252K | Buy |
30,782
+18
| +0.1% | +$466 | ﹤0.01% | 4262 |
|
|
2022
Q3 | $1.31M | Buy |
30,764
+76
| +0.2% | +$4.04K | ﹤0.01% | 3911 |
|
|
2022
Q2 | $1.56M | Buy |
30,688
+401
| +1% | +$19.7K | ﹤0.01% | 3923 |
|
|
2022
Q1 | $1.95M | Sell |
30,287
-6,112
| -17% | -$305K | ﹤0.01% | 3970 |
|
|
2021
Q4 | $1.9M | Sell |
36,399
-37
| -0.1% | -$2.6K | ﹤0.01% | 4061 |
|
|
2021
Q3 | $2.71M | Buy |
36,436
+60
| +0.2% | +$5.14K | ﹤0.01% | 3955 |
|
|
2021
Q2 | $3.65M | Sell |
36,376
-3,023
| -8% | -$300K | ﹤0.01% | 3753 |
|
|
2021
Q1 | $4.69M | Buy |
39,399
+411
| +1% | +$58K | ﹤0.01% | 3565 |
|
|
2020
Q4 | $5.06M | Buy |
38,988
+156
| +0.4% | +$20K | ﹤0.01% | 3350 |
|
|
2020
Q3 | $4.49M | Buy |
38,832
+919
| +2% | +$113K | ﹤0.01% | 3202 |
|
|
2020
Q2 | $5.24M | Buy |
37,913
+30,175
| +390% | +$3.69M | ﹤0.01% | 3079 |
|
|
2020
Q1 | $662K | Buy |
7,738
+15
| +0.2% | +$1.54K | ﹤0.01% | 3609 |
|
|
2019
Q4 | $774K | Buy |
7,723
+802
| +12% | +$88.1K | ﹤0.01% | 3695 |
|
|
2019
Q3 | $980K | Buy |
6,921
+4,778
| +223% | +$885K | ﹤0.01% | 3656 |
|
|
2019
Q2 | $499K | Buy |
+2,143
| New | +$679K | ﹤0.01% | 3827 |
|
Other funds holding AXLA
Vanguard Group's AXLA Position: Q4 2023 in Review
Vanguard Group sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 32,034 shares — an estimated $334K sold.
Vanguard Group first reported a position in AXLA in Q2 2019 and held it in 18 quarters. The position peaked at $5.24M in Q2 2020. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.
- Vanguard Group reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Vanguard Group sold 32,034 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $334K.
- Vanguard Group first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 18 quarters.
- Vanguard Group's Axcella Health Inc. Common Stock position peaked at $5.24M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.
Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.